By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Coming Soon
INTRODUCTION
Ranitidine hydrochloride , sold under the brand name Zantac among others, is a medication used to decrease stomach acid production. It is commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It can be given by mouth, injection into a muscle, or injection into a vein.
In September last year , the probable carcinogen N-nitrosodimethylamine (NDMA) was discovered in ranitidine products from a number of manufacturers, resulting in recalls. In April , ranitidine was withdrawn from the United States market and suspended in the European Union and Australia due to these concerns.
Common side effects include headaches and pain or burning if given by injection. Serious side effects may include cancer, liver problems, a slow heart rate, pneumonia, and the potential of masking stomach cancer. It is also linked to an increased risk of Clostridium difficile colitis.
Ranitidine is an H2 histamine receptor antagonist that works by blocking histamine, thus decreasing the amount of acid released by cells of the stomach. For prevention of acid-aspiration pneumonitis during surgery, it can be administered preoperatively. The drug increases gastric pH, but generally has no effect on gastric volume.
GLOBAL RANITIDINE HYDROCHLORIDE FOR INJECTION MARKET SIZE AND FORECAST
The Global Ranitidine Hydrochloride for Injection Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.
NEW PRODUCT LAUNCH
PFIZER RANITIDINE HYDROCHLORIDERANITIDINE Hydrochloride belongs to the class of gastrointestinal agents. It is used to treat indigestion, heartburn and acid reflux.
RANITIDINE is also used for gastro-oesophageal reflux disease (GORD) when you get acid reflux. RANITIDINE is also used to prevent and treat stomach ulcers. Often RANITIDINE is taken for a rare condition caused by a pancreatic or intestine tumour called Zollinger-Ellison Syndrome.
RANITIDINE contains ranitidine, a histamine-2 (H2) receptor blocker that helps reduce stomach acid by blocking the actions of the H2 receptor. The H2 receptor lies in the parietal cells of the stomach wall and is responsible for the release of gastric acid secretion – extra gastric acid secretion damage the tissues in the food pipe, stomach, and duodenum.
COMPANY PROFILE
THIS REPORT WILL ANSWER FOLLOWING QUESTIONS
